Nontuberculous Mycobacterial Infections Market Poised for Remarkable Growth by 2034, Reports DelveInsight
Several companies, including the AN2 Therapeutics, MannKind Corporation, and others, are actively advancing treatments in the NTM Infections market. LAS VEGAS, NV, UNITED STATES, December 26, 2024 /EINPresswire.com/ -- DelveInsight’s “NTM …